2026-05-28_家用呼吸道检测与CGM竞争格局资料摘录

• 来源: iHealth 官网；Mordor Intelligence 网页
• 日期: 2026-05-28
• 类型: 行业与竞品资料摘录
• 涉及公司: 九安医疗（002432.SZ）；Abbott；Dexcom；Medtronic
• 涉及主题: 家用呼吸道检测；RSV/COVID/Flu 四联检；CGM；连续血糖监测竞争格局
• 一句话摘要: 记录 iHealth 四联检产品页面与 Mordor CGM 市场格局数据，用于九安医疗家用检测和 CGM 竞争分析。

家用呼吸道检测与 CGM 竞争格局资料摘录

Shop RSV+ Covid-19 + Flu A&B At-Home Test Kits—Easy, Fast, and Reliable

– iHealth Labs Inc

文件：2026-05-28_iHealth_4in1_product_page.html

Meta description: Shop and buy the web’s most reliable and convenient RSV, COVID-19, and Flu A&B combination test kits from iHealth Labs. Free, fast shipping. Usable for people over 6 months old, with results in as little as 15 minutes. Remember - treatment cannot begin until you know you’re sick! Buy Today!

• 4-in-1 snippet: Health Cloud Search Sign in Cart 0 items Products Remote Patient Monitoring Enterprise Purchase Support Support Menu Support Contact us Privacy Policy iHealth Cloud # Clinically Inspired iHealth Flu A/Flu B/COVID-19/RSV 4-in-1 Rapid Test Now with RSV More Protection for Kids & Seniors 4-in-1 Detection: COVID-19, Flu A/B & RSV RSV Added: Better protection for kids & seniors 15-Min Results: Fast at-home answers Easy to Use: Simple and convenient testing Clinically Trusted: FDA-Cleared & 1B+ tests supplied Choice Style 10 Tests 2 Tests 5 Tests 96 Tests Regular Price $109.99$149.94 $129.99$149.94 Early-bird Price $89.99Quantity$109.

• RSV snippet: Shop RSV+ Covid-19 + Flu A&B At-Home Test Kits—Easy, Fast, and Reliable – iHealth Labs Inc Skip to content Submit Close search Products Remote Patient Monitoring Enterprise Purchase Support Contact us Privacy Policy iHealth Cloud Search Sign in Cart 0 items Products Remote Patient Monitoring Enterprise Purchase Support Support Menu Support Contact us Privacy Policy iHealth Cloud # Clinically Inspired iHealth Flu A/Flu B/C

• COVID snippet: Shop RSV+ Covid-19 + Flu A&B At-Home Test Kits—Easy, Fast, and Reliable – iHealth Labs Inc Skip to content Submit Close search Products Remote Patient Monitoring Enterprise Purchase Support Contact us Privacy Policy iHealth Cloud Search Sign in Cart 0 items Products Remote Patient Monitoring Enterprise Purchase Support Support Menu Support Contact us Privacy Policy iHealth Cloud # Clinically Inspired iHealth Flu A/Flu B/COVID-

• Flu snippet: Shop RSV+ Covid-19 + Flu A&B At-Home Test Kits—Easy, Fast, and Reliable – iHealth Labs Inc Skip to content Submit Close search Products Remote Patient Monitoring Enterprise Purchase Support Contact us Privacy Policy iHealth Cloud Search Sign in Cart 0 items Products Remote Patient Monitoring Enterprise Purchase Support Support Menu Support Contact us Privacy Policy iHealth Cloud # Clinically Inspired iHealth Flu A/Flu B/COVID-19/RSV 4-in

• 15 minutes snippet: congestion, fatigue—these symptoms blur together. The iHealth 4-in-1 test helps you find out which virus it is so you can take the right next steps. Easy to use When Someone Gets Sick, You Need Answers Fast. Results in 15 minutes, so you know how to act quickly Symptoms Notice signs of illness and decide to test. Test Simple, at-home nasal swab in minutes. Results in 15 minutes Get clear results fast to make informed decisions. Easy as COVID & Flu Testing The most comprehensive test yet—especially for families with little ones, aging parents, or anyone vulnerable. 1 Swab Insert the swab into your nostril and swab against the inner

Continuous Glucose Monitoring Market Size & Share Analysis | 2031

文件：2026-05-28_Mordor_CGM_market.html

Meta description: The Continuous Glucose Monitoring (CGM) Market worth USD 15.33 billion in 2026 is growing at a CAGR of 15.42% to reach USD 31.38 billion by 2031. Medtronic Plc, Dexcom, Inc., Abbott Laboratories, Senseonics Holdings, Inc. and F. Hoffmann-La Roche AG are the major companies operating in this market.

• Abbott snippet: ric users accounted for 34.65% of 2025 revenue and are advancing at an 17.85% CAGR through 2031. By geography, North America retained 50.55% revenue share in 2025; Asia Pacific is forecast to post a 15.78% CAGR to 2031. Abbott Laboratories (56.30%), Dexcom (35.10%), and Medtronic (6.88%) together controlled 98.28% of 2025 shipments, underscoring the market’s high concentration. Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026. Global Continuous Glucose Monitoring (CGM) Market Trends and Insi

• Dexcom snippet: of 2025 revenue and are advancing at an 17.85% CAGR through 2031. By geography, North America retained 50.55% revenue share in 2025; Asia Pacific is forecast to post a 15.78% CAGR to 2031. Abbott Laboratories (56.30%), Dexcom (35.10%), and Medtronic (6.88%) together controlled 98.28% of 2025 shipments, underscoring the market’s high concentration. Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026. Global Continuous Glucose Monitoring (CGM) Market Trends and Insights Drivers Impact Analysis *

• Medtronic snippet: are advancing at an 17.85% CAGR through 2031. By geography, North America retained 50.55% revenue share in 2025; Asia Pacific is forecast to post a 15.78% CAGR to 2031. Abbott Laboratories (56.30%), Dexcom (35.10%), and Medtronic (6.88%) together controlled 98.28% of 2025 shipments, underscoring the market’s high concentration. Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026. Global Continuous Glucose Monitoring (CGM) Market Trends and Insights Drivers Impact Analysis * Driver (~) % Impact

• 56.30 snippet: or 34.65% of 2025 revenue and are advancing at an 17.85% CAGR through 2031. By geography, North America retained 50.55% revenue share in 2025; Asia Pacific is forecast to post a 15.78% CAGR to 2031. Abbott Laboratories (56.30%), Dexcom (35.10%), and Medtronic (6.88%) together controlled 98.28% of 2025 shipments, underscoring the market’s high concentration. Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026. Global Continuous Glucose Monitoring (CGM) Market Trends and Insights Drivers Impact A

• 35.10 snippet: revenue and are advancing at an 17.85% CAGR through 2031. By geography, North America retained 50.55% revenue share in 2025; Asia Pacific is forecast to post a 15.78% CAGR to 2031. Abbott Laboratories (56.30%), Dexcom (35.10%), and Medtronic (6.88%) together controlled 98.28% of 2025 shipments, underscoring the market’s high concentration. Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026. Global Continuous Glucose Monitoring (CGM) Market Trends and Insights Drivers Impact Analysis * Driver

• 98.28 snippet: h 2031. By geography, North America retained 50.55% revenue share in 2025; Asia Pacific is forecast to post a 15.78% CAGR to 2031. Abbott Laboratories (56.30%), Dexcom (35.10%), and Medtronic (6.88%) together controlled 98.28% of 2025 shipments, underscoring the market’s high concentration. Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026. Global Continuous Glucose Monitoring (CGM) Market Trends and Insights Drivers Impact Analysis * Driver (~) % Impact on CAGR Forecast Geographic Relevance

• North America snippet: 026 - 2031) The Continuous Glucose Monitoring (CGM) Market Report is Segmented by Component (Sensors, Transmitters, Receivers), End User (Hospitals/Clinics, Home/Personal), Demography (Adult, Paediatric), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD). Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Monitoring Devices Research Continuous Glucose Monitoring (CGM) Market About This Report Market Size & Share Market Analysis Trends and Insights Segment Analysis Geography Analysis Competiti

• USD 15.33 billion snippet: Major Players Industry Developments Table of Contents SCOPE OF THE REPORT Frequently Asked Questions Continuous Glucose Monitoring (CGM) Market Size and Share Market Overview Study Period 2022 - 2031 Market Size (2026) USD 15.33 Billion Market Size (2031) USD 31.38 Billion Growth Rate (2026 - 2031) 15.42% CAGR Fastest Growing Market North America Largest Market North America Market Concentration High Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. Select Another Geo

关联页面

• 公司页：九安医疗(002432.SZ)